SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001842952-23-000048
Filing Date
2023-04-06
Accepted
2023-04-06 16:02:25
Documents
4
Period of Report
2023-05-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A cntx2023proxyapril62023.htm DEF 14A 467390
2 contexttherapeuticsinc_v001.jpg GRAPHIC 122021
3 contexttherapeuticsinc_v002.jpg GRAPHIC 122084
4 downloada.jpg GRAPHIC 12205
  Complete submission text file 0001842952-23-000048.txt   821774
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

IRS No.: 863738787 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40654 | Film No.: 23806146
SIC: 2834 Pharmaceutical Preparations